E-LIB Suche - Ergebnisse für: Alexander W. MacFarlane

1

A Phase II Trial of Guadecitabine plus Atezolizumab in Meta..:

Jang, H. Josh ; Hostetter, Galen ; Macfarlane, Alexander W....
Clinical Cancer Research. 29 (2023) 11 - p. 2052-2065 , 2023

Link: https://doi.org/10.1158/..

2

mTOR-Dependent and Independent Survival Signaling by PI3K i..:

Kaileh, Mary ; Vazquez, Estefania ; MacFarlane, Alexander W....
PLOS ONE. 11 (2016) 1 - p. e0146955 , 2016

Link: https://doi.org/10.1371/..

3

Hydrophobic Distal Pocket Affects NO−Heme Geminate Recombin..:

Franzen, Stefan ; Jasaitis, Audrius ; Belyea, Jennifer...
The Journal of Physical Chemistry B. 110 (2006) 29 - p. 14483-14493 , 2006

Link: https://doi.org/10.1021/..

4

A phase 1 study of nivolumab in combination with interferon..:

Zibelman, Matthew ; MacFarlane IV, Alexander W. ; Costello, Kimberly...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

5

Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Ve..:

Zhigarev, Dmitry ; Varshavsky, Asya ; MacFarlane IV, Alexander W....
Cancers. 14 (2022) 14 - p. 3352 , 2022

Link: https://doi.org/10.3390/..

6

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2..:

Ford, Jill W. ; Gonzalez-Cotto, Marieli ; MacFarlane IV, Alexander W....
Frontiers in Oncology. 11 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

Alterations of NK Cell Phenotype in the Disease Course of M..:

Pazina, Tatiana ; MacFarlane IV, Alexander W. ; Bernabei, Luca...
Cancers. 13 (2021) 2 - p. 226 , 2021

Link: https://doi.org/10.3390/..

8

Impacts of pembrolizumab therapy on immune phenotype in pat..:

MacFarlane IV, Alexander W. ; Yeung, Ho-Man ; Alpaugh, R. Katherine...
Cancer Immunology, Immunotherapy. 70 (2021) 7 - p. 1893-1906 , 2021

Link: https://doi.org/10.1007/..

9

Immune phenotype of patients with stage IV metastatic infla..:

Fernandez, Sandra V. ; MacFarlane IV, Alexander W. ; Jillab, Mowafaq...
Breast Cancer Research. 22 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

10

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the ..:

Barta, Stefan K. ; Zain, Jasmine ; MacFarlane IV, Alexander W....
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 6 - p. 356-364.e3 , 2019

Link: https://doi.org/10.1016/..

11

Application of 3D tumoroid systems to define immune and cyt..:

Finnberg, Niklas K. ; Gokare, Prashanth ; Lev, Avital...
Oncotarget. 8 (2017) 40 - p. 66747-66757 , 2017

Link: https://doi.org/10.18632..

12

The anti-SLAMF7 antibody elotuzumab mediates NK cell activa..:

Pazina, Tatiana ; James, Ashley M. ; MacFarlane IV, Alexander W....
OncoImmunology. 6 (2017) 9 - p. e1339853 , 2017

Link: https://doi.org/10.1080/..

13

NK cell dysfunction in chronic lymphocytic leukemia is asso..:

MacFarlane IV, Alexander W. ; Jillab, Mowafaq ; Smith, Mitchell R....
OncoImmunology. , 2017

Link: https://doi.org/10.1080/..

14

B-cell adaptor for PI3K (BCAP) negatively regulates Toll-li..:

Ni, Minjian ; MacFarlane IV, Alexander W. ; Toft, Michelle...
Proceedings of the National Academy of Sciences of the United States of America. 109 (2012) 1 - p. 267-272 , 2012

Link: https://www.jstor.org/st..

15

B-cell adaptor for PI3K (BCAP) negatively regulates Toll-li..:

Ni, Minjian ; MacFarlane IV, Alexander W. ; Toft, Michelle...
Proceedings of the National Academy of Sciences. 109 (2011) 1 - p. 267-272 , 2011

Link: https://doi.org/10.1073/..